Duopharma Biotech Berhad (KLSE:DPHARMA)

Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	264.55	270.5	157.64	137.98	158.03
Cash & Short-Term Investments	264.55	270.5	157.64	137.98	158.03
Cash Growth	-2.20%	71.60%	14.25%	-12.69%	30.96%
Accounts Receivable	184.33	135.04	131.31	122.42	112.99
Other Receivables	23.59	26.38	10.84	10.31	22.18
Receivables	207.92	161.42	142.15	132.72	135.17
Inventory	248.55	243.07	235.18	222.19	151.27
Prepaid Expenses	5.39	2.08	6.52	1.9	0.67
Other Current Assets	-	-	-	-	14.56
Total Current Assets	726.4	677.07	541.49	494.8	459.69
Property, Plant & Equipment	567.52	582.37	579.92	542.53	441.79
Long-Term Investments	22.67	36.91	42.15	73.54	112.25
Other Intangible Assets	7.32	7.65	3.84	4.95	4.66
Long-Term Deferred Tax Assets	15.33	8.95	13.33	12.7	8.54
Long-Term Deferred Charges	37.55	31.15	40.14	34.58	30.41
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.1
Total Assets	1,378	1,345	1,222	1,164	1,058
Accounts Payable	55.89	40.45	51.93	31.32	28.15
Accrued Expenses	46.92	33.79	40.46	61.2	45.62
Short-Term Debt	32.33	50.59	101.8	87.85	36.11
Current Portion of Long-Term Debt	15.66	14.95	32.34	15.08	12.68
Current Portion of Leases	0.55	0.92	0.94	0.64	0.6
Current Income Taxes Payable	0.74	0.37	1.17	6.06	0.74
Other Current Liabilities	25.89	25.65	35.95	28.17	26.41
Total Current Liabilities	177.99	166.73	264.59	230.31	150.32
Long-Term Debt	464.52	480.9	294.6	297.8	253.28
Long-Term Leases	2.76	1.48	1.92	2.48	0.66
Long-Term Deferred Tax Liabilities	23.42	8.91	5.58	9.54	10.35
Total Liabilities	668.68	658.01	566.7	540.13	414.61
Common Stock	432.47	432.47	419.37	405.86	404.92
Retained Earnings	354.78	319.07	288.37	239.97	220.18
Comprehensive Income & Other	-78.09	-64.41	-52.52	-21.82	18.72
Shareholders' Equity	709.15	687.12	655.22	624	643.82
Total Liabilities & Equity	1,378	1,345	1,222	1,164	1,058
Total Debt	515.82	548.85	431.6	403.84	303.33
Net Cash (Debt)	-251.28	-278.35	-273.97	-265.86	-145.31
Net Cash Per Share	-0.26	-0.29	-0.29	-0.29	-0.16
Filing Date Shares Outstanding	961.94	961.94	952.24	941.77	941.37
Total Common Shares Outstanding	961.94	961.94	952.24	941.77	941.37
Working Capital	548.42	510.34	276.9	264.49	309.37
Book Value Per Share	0.74	0.71	0.69	0.66	0.68
Tangible Book Value	701.84	679.47	651.38	619.06	639.16
Tangible Book Value Per Share	0.73	0.71	0.68	0.66	0.68
Land	65.68	65.68	69.88	69.88	69.88
Buildings	267.09	265.86	125.23	124.51	119.57
Machinery	452.39	435.18	368.47	308.94	291.64
Construction In Progress	12.19	8.48	172.65	162.63	65.81

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.